XML 69 R58.htm IDEA: XBRL DOCUMENT v3.23.2
Subsequent Events (Details)
$ / shares in Units, $ in Millions
 6 Months Ended
Aug. 10, 2023
USD ($)
employee
$ / shares
Jun. 30, 2023
$ / shares
Subsequent Event [Line Items]    
Exercise price of options (in dollars per share) | $ / shares   $ 1.64
Subsequent Event | GeneFab    
Subsequent Event [Line Items]    
Consideration received in collaborative development agreement $ 37.8  
Upfront payment under research collaboration and license agreement 18.9  
Revenue, remaining performance obligation, additional consideration 18.9  
Prepayments for manufacturing and research activities 18.9  
Revenue, remaining performance obligation, manufacturing credits $ 8.0  
Employment offer, number of employees | employee 46  
Option to purchase common stock, value $ 20.0  
Exercise price of options (in dollars per share) | $ / shares $ 1.01867  
Expiration period (in years) 36 months  
Revenue, remaining performance obligation, variable consideration, percentage of realized ganis 10.00%